Senores Pharmaceuticals Ltd.
SENORES Share PricePharmaceuticals & Drugs
₹736.45
-8.9 (-1.2%)
As on September 9, 2025
Exchange Scrips: BSE544319NSESENORESISININE0RB801010
Market Cap ₹ 3,390 Cr
P/E Ratio 71.42
Dividend Yield N/A
Performance
Market performance
Open745.1
High751.2
Volumes2,48,794
Prev736.45
Low726.25
As on2025-09-09
Historical performance
1 Year High751.2
3 Year High751.2
5 Year High751.2
1 Year Low435.25
3 Year Low435.25
5 Year Low435.25
Fundamentals
Company Valuation
Market Cap (₹Cr)
3,390
Face Value (₹)
10
P/E Ratio
71.42
Dividend Yield
N/A
Investment Returns
1 Year
N/A
3 Years
N/A
5 Years
N/A
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 723.54 | Bullish |
| 10-DMA | 711.12 | Bullish |
| 20-DMA | 702.51 | Bullish |
| 50-DMA | 658.26 | Bullish |
| 100-DMA | 591.2 | Bullish |
| 200-DMA | --- |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|
| Promoters | 16 | 16 | 16 | 16 |
| Foreign Investors | 3 | 3 | 3 | 3 |
| Domestic Investors | 13 | 13 | 13 | 13 |
| Public Investors | 36373 | 37637 | 49502 | 43691 |
| Government | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 71.42.
- 3Y Stock Price CAGR of the stock is None.
- The stock has a beta of 1.5.
- In the last financial year, the company had an EBITDA of ₹444 Million.
- The company generated revenue of ₹2145 Million in the previous financial year.
Senores Pharmaceuticals Ltd.
736.45-8.9 (-1.2%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1322053.7
No. of Shares: 1795 (Approx)
Performance:32.2%
P/L: ₹322053.7
Top Gainers
| Symbol | Change% |
|---|---|
| ITDC | 653.6(20%) |
| LASA | 12.74(20%) |
| PRECAM | 254.93(16%) |
| JTEKTINDIA | 181.94(15%) |
| QUICKHEAL | 335.1(14%) |
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent